Journal of the American Chemical Society p. 4297 - 4305 (1988)
Update date:2022-07-31
Topics:
Sigman, Michael E.
Autrey, Tom
Schuster, Gary B.
The photochemistry of 4-acetylbenzoyl azide (ABA), 4-acetyl-4'-biphenoyl azide (ADA), and 4-acetylphenoxycarbonyl azide (APA) shows unusual wavelength and structrural effects.Irradiation of ABA or ADA into their ?-?* bands with deep-UV light leads to formation of 4-acetylbenzoylnitrene (ABN) and 4-acetyl-4'-biphenylnitrene (ADN), respectively, in competition with photo-Curtis rearrangement to form isocyanates.Irradiation of these azides into their n-?* bands with near-UV light gives only the aroylnitrenes.The triplet excited states of the azides were detected chemically and by transient spectroscopic techniques.Nitrogen loss following near-UV irradiation occurs exclusively from the excited triplet azides.However, the chemical properties of ABN and ADN are consistent only with reactions originating from their singlet states.An ESR spectrum is observed at 8 K for ((4-acetylphenoxy)carbonyl)nitrene (APN) but not for 4-acetylbenzoylnitrene (ABN) of 4-acetyl-4'-biphenylcarbonylnitrene (ADN).The chemical properties of APN in tert-butyl alcohol show that its triplet is no more than 5 kcal/mol below its lowest single state.In contrast, the chemical properties of ABN and ADN indicate that these niterenes have singlet ground states.
View MoreYanCheng LongShen Chemical Co.,Ltd.
Contact:+86-515-86668866
Address:No.13,Weiyi Road,Funing Aoyang Industrial Park
Shantou Baokang Pharmaceutical Co., Ltd.
Contact:+86-754-88873487
Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou
Huaihua Baohua Biotechnology Co.,Ltd
website:http://www.baochengchem.com
Contact:86-519-82698291
Address:HouYang chemical development zone,Jintan,Jiangsu,China (213200)
website:https://www.sinoshiny.com/products
Contact:+86-20-62802632;62802633
Address:Room 330 GIGCAS Building,No.511 Kehua Street,Tianhe District
Shanghai Taibao Pharmaceutical Technology Co., Ltd(expird)
Contact:021-52217366
Address:shanghai
Doi:10.1248/cpb.35.632
(1987)Doi:10.1016/S0040-4020(01)89178-X
(1989)Doi:10.1016/j.tet.2011.05.016
(2011)Doi:10.1039/c2cc16611a
(2012)Doi:10.1039/d1tc01079d
(2021)Doi:10.1016/j.ijpharm.2010.06.036
(2010)